Schedule 13G ownership disclosure

SALIX PHARMACEUTICALS LTD

Security class unavailable · CUSIP: 795435106

Event date: 2014-11-07

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-14-415168
Form type
SC 13G/A
Filer
SALIX PHARMACEUTICALS LTD
CIK
CIK 1009356
Filed
Nov 17, 2014
Reporting period
Nov 07, 2014
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub